Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis Type 2”

89 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 89 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03190915
What this trial is testing

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

Who this might be right for
Juvenile Myelomonocytic LeukemiaNeurofibromatosis Type 1
National Cancer Institute (NCI) 10
Not applicableUnknownNCT05821790
What this trial is testing

Role of the Tumor Microenvironment in Aggressive Meningiomas

Who this might be right for
Meningioma
Assistance Publique - Hôpitaux de Paris 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02407405
What this trial is testing

MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1 (NF1)Plexiform Neurofibromas (PN)
National Cancer Institute (NCI) 36
Not applicableActive Not RecruitingNCT04759781
What this trial is testing

MElanoma Research Lymph Node Prediction Implementation National_001

Who this might be right for
Melanoma
SkylineDx 1,820
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05253131
What this trial is testing

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

Who this might be right for
MPNSTNF1Sarcoma
University of Alabama at Birmingham 41
Not applicableStudy completedNCT02246231
What this trial is testing

Effect of Implant Position on Magnetic Resonance Image Distortion

Who this might be right for
Neurofibromatosis Type 2
Manchester University NHS Foundation Trust 5
Testing effectiveness (Phase 2)Study completedNCT02352844
What this trial is testing

Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations

Who this might be right for
Solid MalignancySolid Tumor
Washington University School of Medicine 12
Testing effectiveness (Phase 2)Ended earlyNCT01345136
What this trial is testing

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

Who this might be right for
Neurofibromatosis Type 2Neuroma, Acoustic
Jonsson Comprehensive Cancer Center 4
Not applicableLooking for participantsNCT00598351
What this trial is testing

Natural History Study of Patients With Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis
National Institute of Neurological Disorders and Stroke (NINDS) 269
Testing effectiveness (Phase 2)Study completedNCT03433183
What this trial is testing

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath TumorsNeurofibromatosis 1
Sarcoma Alliance for Research through Collaboration 21
Testing effectiveness (Phase 2)Looking for participantsNCT06541847
What this trial is testing

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis Type 1
Healx Limited 25
Testing effectiveness (Phase 2)Looking for participantsNCT06188741
What this trial is testing

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibroma
University of Alabama at Birmingham 200
Not applicableStudy completedNCT02298270
What this trial is testing

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Who this might be right for
NeurofibromatosisNeurofibromatosis INeurofibromatosis 2+1 more
Massachusetts General Hospital 65
Not applicableStudy completedNCT03406208
What this trial is testing

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Who this might be right for
NeurofibromatosesNeurofibromatosis 1Neurofibromatosis 2+1 more
Massachusetts General Hospital 228
Not applicableStudy completedNCT02435628
What this trial is testing

Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF

Who this might be right for
Neurofibromatosis
Massachusetts General Hospital 86
Testing effectiveness (Phase 2)WithdrawnNCT03688568
What this trial is testing

Study of Imatinib in Children With Neurofibromatosis and Airway Tumors

Who this might be right for
Neurofibroma, Plexiform
Indiana University
Testing effectiveness (Phase 2)Study completedNCT00589784
What this trial is testing

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Who this might be right for
CNS CancerMeningiomaIntracranial Hemangiopericytoma+2 more
Memorial Sloan Kettering Cancer Center 50
Early research (Phase 1)WithdrawnNCT01850225
What this trial is testing

Feasibility Study of Auditory Brainstem Implant in Young Children

Who this might be right for
Bilateral Cochlear AplasiaBilateral Cochlear Nerve DeficiencyBilateral Cochlear Ossification Secondary to Meningitis
House Research Institute
Not applicableLooking for participantsNCT01885767
What this trial is testing

Neurofibromatosis (NF) Registry Portal

Who this might be right for
Neurofibromatosis 1Neurofibromatosis 2Schwannomatosis
The Children's Tumor Foundation 20,000
Early research (Phase 1)Study completedNCT02102256
What this trial is testing

A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients

Who this might be right for
Profound Bilateral Deafness Due toBilateral Cochlear AplasiaBilateral Cochlear Nerve Deficiency+1 more
Laurie Eisenberg 10
Load More Results